Investing Ideas
/
Malaysian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Malaysian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses

4 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
AHEALTH Apex Healthcare Berhad	RM 2.46	-1.6%	-5.4%	RM 1.8b	RM 2.91	PE21.3x	E12.0%	10.6%
KOTRA Kotra Industries Berhad	RM 4.44	0.9%	-6.5%	RM 658.5m	RM 4.81	PE16.2x	E15.5%	5.7%
RHONEMA Rhone Ma Holdings Berhad	RM 0.68	0.7%	-4.2%	RM 150.4m	RM 0.70	PE12x	E5.8%	1.5%
MGRC Malaysian Genomics Resource Centre Berhad	RM 0.34	-6.8%	-23.3%	RM 47.3m	n/a	PS5.3x	n/a	0%

Page 1 of 1